Filling the gap between excellence in basic cancer research and unmet needs in targeted cancer therapies.
Cancer Therapeutics CRC has a pipeline of innovative early stage small molecule oncology programs, backed up with data-rich packages, which are available for partnering.
We seek to establish partnerships with pharmaceutical and biotechnology companies who are best placed to take our assets to the next stage.
Our programs fill the gap between excellence in basic cancer research and unmet needs in targeted cancer therapies.
We also invite submissions about promising novel targets for in-licensing or partnered development.
The Australian Government provides tax incentives through the Australian R&D Tax Incentive Program for firms that partner for innovation.